Zhejiang Hisun Pharmaceutical, Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Hisun Pharmaceutical, Ltd. with three other
companies in this sector in China:
Joincare Pharmaceutical Group Industry Company Limited
sales of 9.72 billion Chinese Renmimbi [US$1.44 billion]
of which 99%
was Industry and Commerce),
Xin Jiang Ready Health Industry Co Ltd
(9.00 billion Chinese Renmimbi [US$1.33 billion]
of which 86%
was Pharmaceutical - Wholesale), and
Shanghai Shyndec Pharmaceutical Co Ltd
(9.12 billion Chinese Renmimbi [US$1.35 billion]
of which 49%
was Drug Products).
Zhejiang Hisun Pharmaceutical, Ltd. reported sales of 9.73 billion Chinese Renmimbi (US$1.44 billion)
December of 2016.
increase of 11.0%
versus 2015, when the company's sales were 8.77 billion Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2014, when Zhejiang Hisun Pharmaceutical, Ltd.
reported sales of 10.10 billion Chinese Renmimbi.
Sales of Drug/medicine Sales saw an increase
11.4% in 2016, from
5.62 billion Chinese Renmimbi to 6.26 billion Chinese Renmimbi.
Not all segments of Zhejiang Hisun Pharmaceutical, Ltd. experienced an increase in sales in 2016:
sales of Other, Main Operations fell 98.1% to 6,837.61 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).